Mast cells and eosinophils have a potential profibrogenic role in crohn disease

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 5, 2004, Pages 440-447

  Xu, X ^b   Rivkind, A ^b   Pikarsky, A ^b   Pappo, O ^b   Bischoff, S C ^b   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

Crohn disease; Eosinophils; Fibroblasts; Fibrosis; Mast cells

Indexed keywords

ALPHA ACTIN; COLLAGEN ANTIBODY; COLLAGEN TYPE 4 ANTIBODY; COLLAGEN TYPE 7 ANTIBODY; LAMININ; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROHN DISEASE; EOSINOPHIL; EOSINOPHILIA; EXTRACELLULAR MATRIX; FETUS CELL; FIBROBLAST CULTURE; FIBROGENESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTESTINAL FIBROSIS; INTESTINE BIOPSY; INTESTINE CELL; MAST CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; COLON; CROHN DISEASE; EOSINOPHILS; FIBROBLASTS; FIBROSIS; HUMANS; INFLAMMATION MEDIATORS; MAST CELLS;

EID: 2442618980     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310008566     Document Type: Article

References (46)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. 1 Paracrine cells important in health and disease. Am J Physiol 1999;277:C1-9.
3. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II Intestinal subepithelial myofibroblasts. Am J Physiol 1999;277:C183-201.
4. Trojanowska M, LeRoy EC, Eckes B, Krieg T. Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med 1998;76:266-74.
5. Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflammatory Bowel Dis 2001;7:226-36.
6. Hashimoto S, Gon Y, Takeshita I, Maruoka S, Horie T. IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway. J Allergy Clin Immunol 2001;107:1001-8.
7. Smith S, Levi-Schaffer F. Mast cell-eosinophil-fibroblast cross-talk in allergic inflammation. In: Robinson DS, editor. Immunological mechanisms in asthma and allergic diseases. Chem Immunol London: Karger; 2000. p. 78, 81-92.
8. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
9. Xu X, Weksler-Zangen S, Pikarsky A, Pappo O, Wengrower D, Bischoff SC, et al. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 2002;37:330-7.
10. Ruger B, Dunbar PR, Hasan Q, Sawada H, Kittelberger R, Greenhill N, et al. Human mast cells produce type VIII collagen in vivo. Int J Exp Path 1994;75:397-404.
11. Thompson HL, Burbelo PD, Gabriel G, Yamada Y, Metcalfe DD. Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest 1991;87:619-23.
12. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110:975-84.
13. Bischoff SC, Grabowsky J, Manns MP. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997;42:394-403.
14. Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enterpathy. Int Arch Allergy Immunol 1995;108:127-33.
15. Weller PF. Human eosinophils. J Allergy Clin Immunol 1997; 100:283-7.
16. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils. Immunol Rev 2001;179:139-55.
17. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995;37:242-6.
18. Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel diseases. Am J Gastroenterol 1999;94:3521-9.
19. WinterKamp S, Raithel M, Hahn EG. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. J Clin Gastroenterol 2000;30:170-5.
20. Jeziorska M, Haboubi N, Schofield P, Woolley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 2001;194:484-92.
21. Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36:120-5.
22. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, et al. Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 1994;39:489-98.
23. Bischoff SC, Selige G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999;96:8080-5.
24. Levi-Schaffer F, Garbuzenko E, Rubin A, Reich R, Pickholz D, Gillery P, et al. Human eosinophils regulate human lung and skin-derived fibroblast properties in vitro: a role for transforming growth factor β(TGF-β). Proc Natl Acad Sci USA 1999;96:9660-5.
25. Schwartz LB, Bradford TR. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 1986;261:7372-9.
26. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997;151:317-22.
27. Okazawa A, Kanai T, Watanabe M, Yamazaki M, Inoue N, Ikeda M, et al. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement. Am J Gastroenterol 2002;97:3108-17.
28. Kontoyiannis D, Boulougouris G, Manoloukos M, Armaka M, Apostolaki M, Pizarro T, et al. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J Exp Med 2002;196:1563-74.
29. Kanai T, Watanabe M, Okazawa A, Sato T, Hibi T. Interleukin-18 and Crohn's disease. Digestion 2001;63:37-42.
30. Chen W, Paulus B, Shu D, Wilson, Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol 2001;36:515-20.
31. Xia HZ, Kepley CL, Sakai K, Chelliah J, Irani AM, Schwartz LB. Quantitation of tryptase, chymase, FcεR1α, and FcεR1γ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995;154:5472-80.
32. Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart FX, Levi-Schaffer F. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy 2002;32:237-46.
33. Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F. Role of mast cells and myofibroblasts in human peritoneal adhesion formation. Ann Surg 2002;236:593-601.
34. Taniguchi S, Furukawa M, Kono T, Hisa T, Ishii M, Hamada T. Butylated hydroxyanisole blocks the inhibitory effects of tumor necrosis factor-alpha on collagen production in human dermal fibroblasts. J Dermatol Sci 1996;12:44-9.
35. Siwik DA, Chang DL, Colucci WS. Interleukin-1β and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000;86:1259-65.
36. Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR, Willis RA, et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994;72:283-92.
37. Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003;124:1866-78.
38. Jelaska A, Strehlow D, Korn JH. Fibroblasl heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol 1999;21:385-95.
39. Rogler G, Gelbmann CM, Vogl D, Brunner M, Scholmerich J, Falk W, et al. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol 2001;36:389-98.
40. McKaig BC, Hughes K, Tighe PJ, Mahida YR. Differential expression of TGF isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol 2002;288:C172-82.
41. Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazuma S, et al. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J Gastroenterol 2003;38:229-37.
42. Abe M, Kurosawa M, Ishikawa O, Miyachi Y. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol 2000;106:578-84.
43. Hernnas J, Sarnstrand B, Lindroth P, Peterson CG, Venge P, Malmstrom A. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992;59:352-63.
44. Rochester CL, Ackerman SJ, Zheng T, Elias JA. Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 1996;156:4449-56.
45. Furuta GT, Ackerman SJ, Varga J, Spiess AM, Wang MY, Wershil BK. Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin Exp Immunol 2000;122:35-40.
46. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162-7.